Grey Wolf Therapeutics Closes USD 49M Series B Financing

-



Grey Wolf Therapeutics Oxford UK based biotechnology company focused on generating entirely novel anti tumour immune responses through targeted cancer neoantigen creation raises USD 49M Series B funding The round led by Pfizer Ventures



Source link

Latest news

Age Verification Is Reaching a Global Tipping Point. Is TikTok’s Strategy a Good Compromise?

Governments worldwide are moving to limit children’s access to social media as lawmakers question whether platforms are capable...

The Math on AI Agents Doesn’t Add Up

The big AI companies promised us that 2025 would be “the year of the AI agents.” It turned...

I Tested 20 Over-the-Counter Sleep Aids to Find a Way to Beat My Insomnia

Others TestedThese were effective, but not as consistently so as the above picks. I'd still encourage others to...

This Is Easily the Best Gaming Laptop You Can Buy Under $1,000

I'm always on the hunt for cheap gaming laptops that don’t suck, but let’s be real—many of them...

The Roborock Qrevo Curv 2 Flow Is Gorgeous and Reasonably Priced

The Qrevo Curv 2 Flow is also optimized for hardwood floors. SmartPlan had no trouble automatically distinguishing the...

No, the Freecash App Won’t Pay You to Scroll TikTok

I first encountered the Freecash app after clicking on a sponsored TikTok video with dubious claims. The advertisement...

Must read

You might also likeRELATED
Recommended to you